Why the study?
Evidence-based studies concerning the correlation between impaired lipid metabolism, glycemic control, and cardiometabolic complications in Yemeni patients with T2DM were scarce.
Is poor glycemic control (elevated HbA1c) associated with adverse serum lipid profile abnormalities in patients with type 2 diabetes mellitus?
Cross-Sectional (n=145)
No
Is poor glycemic control (elevated HbA1c) associated with adverse serum lipid profile abnormalities in patients with type 2 diabetes mellitus?
Answers are grounded in this paper and cite their sources.
In Yemeni patients with type 2 diabetes, higher HbA1c correlates with elevated total cholesterol, triglycerides, and LDL-C and lower HDL-C, supporting HbA1c as a dual marker for glycemic control and dyslipidemia risk.
Background: A scarcity of evidence-based study concerning the correlation between impaired lipid metabolism and the onset of cardiometabolic complications in Yemeni diabetic patients. Objective: An experimental based cross-sectional study aimed to explore the link between lipid abnormalities and glycemic control in patients with type 2 diabetes mellitus (T2DM). Methods: Out of 145 individuals diagnosed with T2DM were participated in this study. Anthropometric status of chosen patients was measured, isolated blood samples were investigated for fasting blood glucose (FBS), glycated hemoglobin A1c (HbA1c), and fasting serum lipids, including total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C). Descriptive statistics, Pearson’s correlation, and multiple logistic regression were used in data analysis. Results: T2DM patients aged from 20 to 80 years, with an average age of 54.35±8.02 years. 82 males (56.6%) and 63 females (43.4%) were grouped in gender. The majority of subjects (72.4%) were not at diabetic dyslipidemia risk, while 27.6% were counted at risk. Body mass index (BMI), FBS, and HbA1c mean values were 25.02±5.22 kg/m², 0.37±0.489, and 1.67±0.474, respectively. Statistically, a positive association was observed between HbA1c and FBS with BMI, TC, TG, and LDL-C, while negative correlations were found with HDL-C. Diabetic patients with poor glycemic control (HbA1c ≥ 6.0) had shown higher TC, TG, LDL-C, and HDL-C in comparison with subjects had good glycemic control (HbA1c < 6.0). Conclusion: The results demonstrate that HbA1c levels can serve as a predicator marker for manifesting diabetic patients at high risk, facilizing early diagnosis of dyslipidemia and aiding timely treatment with lipid-controlling therapies.
No takes yet. Share an insight, caveat, or question.
Al-Maktari et al. (2026) conducted a cross-sectional in Type 2 diabetes mellitus (n=145). Glycemic control (HbA1c) vs. Good glycemic control (HbA1c < 6.0%) was evaluated on Correlation between HbA1c and fasting serum lipid profile parameters (TC, TG, LDL-C, HDL-C) (p=<0.05).
Synapse has enriched 10 related papers. Consider them for comparative context: